[1] Tham, C.K., Choo, S.P., Poon, D.Y.H., Toh, H.C., Ong, S.Y.K., Tan, S.H., Wang, M.L.C. and Foo, K.F. (2010) Capecitabine with Radiation is an Effective Adjuvant Therapy in Gastric Cancers. World Journal of Gastroenterology, 16, 3709-3715.
http://dx.doi.org/10.3748/wjg.v16.i29.3709
[2] Cunningham, D., Allum, W.H., Stenning, S.P., et al. (2006) Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. The New England Journal of Medicine, 355, 11-20.
http://dx.doi.org/10.1056/NEJMoa055531
[3] Bajetta, E., Buzzoni, R., Mariani, L., Beretta, E., Bozzetti, F., Bordogna, G., Aitini, E., Fava, S., Schieppati, G., Pinotti, G., Visini, M., Ianniello, G. and Di, B.M. (2002) Adjuvant Chemotherapy in Gastric Cancer: 5-Year Results of a Randomised Study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology, 13, 299-307.
http://dx.doi.org/10.1093/annonc/mdf040
[4] Allum, W.H., Hallissey, M.T., Ward, L.C. and Hocke, M.S., British Stomach Cancer Group (1989) A Controlled, Prospective, Randomised Trial of Adjuvant Chemotherapy or Radiotherapy in Resectable Gastric Cancer: Interim Report. British Journal of Cancer, 60, 739-744.
http://dx.doi.org/10.1038/bjc.1989.350
[5] Macdonald, J.S., Smalley, S.R., Benedetti, J., et al. (2001) Chemoradiotherapy after Surgery Compared with Surgery alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction. The New England Journal of Medicine, 345, 725-730.
http://dx.doi.org/10.1056/NEJMoa010187
[6] Macdonald, J.S., Benedetti, J., Smalley, S., et al. (2009) Chemoradiation of Resected Gastric Cancer: A 10-Year Follow up of the Phase III Trial INT 0116 (SWOG 9008). Journal of Clinical Oncology, 27, 15s. (Suppl; abstr 4515).
[7] Wagner, A.D., Grothe, W., Haerting, J., et al. (2006) Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data. Journal of Clinical Oncology, 24, 2903-2909.
http://dx.doi.org/10.1200/JCO.2005.05.0245
[8] Meyerhardt, J.A. and Mayer, R.J. (2005) Systemic Therapy for Colorectal Cancer. The New England Journal of Medicine, 352, 476-487.
http://dx.doi.org/10.1056/NEJMra040958
[9] Cunningham, D., Rao, S., Starling, N., et al. (2006) Randomised Multicentre Phase III Study Comparing Capecitabine with Fluorouracil and Xaliplatin with Cisplatin in Patients with Advanced Oesophagogastric Cancer: The REAL 2 Trial. Journal of Clinical Oncology, 24, 18S.
[10] Jansen, E.P., Boot, H., Saunders, M.P., Crosby, T.D., Dubbelman, R., Bartelink, H., Verheij, M. and Cats, A. (2007) A Phase I-II Study of Postoperative Capecitabine-Based Chemoradiotherapy in Gastric Cancer. International Journal of Radiation Oncology, Biology, Physics, 69, 1424-1428.
http://dx.doi.org/10.1016/j.ijrobp.2007.05.004
[11] Schuller, J., Cassidy, J., Dumont, E., Roos, B., Durston, S., Banken, L., Utoh, M., Mori, K., Weidekamm, E. and Reigner, B. (2000) Preferential Activation of Capecitabine in Tumor Following Oral Administration to Colorectal Cancer Patients. Cancer Chemotherapy and Pharmacology, 45, 291-297.
http://dx.doi.org/10.1007/s002800050043
[12] Kang, Y.K., Kang, W.K., Shin, D.B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., Philco-Salas, M., Suarez, T., Santamaria, J., Forster, G. and McCloud, P.I. (2009) Capecitabine/Cisplatin versus 5-Fluorouracil/Cisplatin as First-Line Therapy in Patients with Advanced Gastric Cancer: A Randomized Phase III Noninferiority Trial. Annals of Oncology, 20, 666-673.
http://dx.doi.org/10.1093/annonc/mdn717
[13] Bosset, J.F., Collette, L., Calais, G., et al. (2006) Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. New England Journal of Medicine, 355, 1114-1123.
http://dx.doi.org/10.1056/NEJMoa060829
[14] Rodel, C., Grabenbauer, G.G., Papadopoulos, T., et al. (2003) Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer. Journal of Clinical Oncology, 21, 3098-3104.
http://dx.doi.org/10.1200/JCO.2003.02.505
[15] Lee, H.S., Choi, Y., Hur, W.J., Kim, H.J., Kwon, H.C., Kim, S.H., Kim, J.S., Lee, J.H., Jung, G.J. and Kim, M.C. (2006) Pilot Study of Postoperative Adjuvant Chemoradiation for Advanced Gastric Cancer: Adjuvant 5-FU/Cisplatin and Chemoradiation with Capecitabine. World Journal of Gastroenterology, 12, 603-607.
[16] Tham, C.K., Choo, S.P., Poon, D.Y., Toh, H.C., Ong, S.Y., Tan, S.H., et al. (2010) Capecitabine with Radiation Is an Effective Adjuvant Therapy in Gastric Cancers. World Journal of Gastroenterology, 16, 3709-3715.
http://dx.doi.org/10.3748/wjg.v16.i29.3709
[17] Hartgrink, H.H., van de Velde, C.J., Putter, H., et al. (2004) Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial. Journal of Clinical Oncology, 22, 2069-2077.
http://dx.doi.org/10.1200/JCO.2004.08.026
[18] Lim, D.H., Kim, D.Y., Kang, M.K., Kim, Y.I., Kang, W.K., Park, C.K., Kim, S., Noh, J.H., Joh, J.W., Choi, S.H., Sohn, T.S., Heo, J.S., Park, C.H., Park, J.O., Lee, J.E., Park, Y.J., Nam, H.R., Park, W., Ahn, Y.C. and Huh, S.J. (2004) Patterns of Failure in Gastric Carcinoma after D2 Gastrectomy and Chemoradiotherapy: A Radiation Oncologist’s View. British Journal of Cancer, 91, 11-17.
http://dx.doi.org/10.1038/sj.bjc.6601896
[19] Kim, S., Lim, K.H., Lee, J., et al. (2005) An Observational Study Suggesting Clinical Benefit for Adjuvant Ostoperative Chemoradiation in a Population of over 500 Cases after Gastric Resection with D2 Nodal Dissection for Adenocarcinoma of the Stomach. International Journal of Radiation Oncology*Biology*Physics, 63, 1279-1285.
http://dx.doi.org/10.1016/j.ijrobp.2005.05.005
[20] Yoo, C.H., Noh, S.H., Shin, D.W., et al. (2000) Recurrence Following Curative Resection for Gastric Carcinoma. British Journal of Surgery, 87, 236-242.
http://dx.doi.org/10.1046/j.1365-2168.2000.01360.x
[21] Shimada, K. and Ajani, J.A. (1999) Adjuvant Therapy for Gastric Carcinoma Patients in the Past 15 Years: A Review of Western and Oriental Trials. Cancer, 86, 1657-1668.
http://dx.doi.org/10.1002/(SICI)1097-0142(19991101)86:9<1657::AID-CNCR6>3.0.CO;2-J
[22] Park, S.H., Kim, D.Y., Heo, J.S., Lim, D.H., Park, C.K., Lee, K.W., Choi, S.H., Sohn, T.S., Kim, S., Noh, J.H., Kim, Y.I., Park, J.O., Kim, K., Kim, W.S., Jung, C.W., Im, Y.H., Lee, M.H., Park, K., Park, C.H. and Kang, W.K. (2003) Postoperative Chemoradiotherapy for Gastric Cancer. Annals of Oncology, 14, 1373-1377.
http://dx.doi.org/10.1093/annonc/mdg366
[23] Kim, J.S., Kim, J.S., Cho, M.J., Yoon, W.H. and Song, K.S. (2006) Comparison of the Efficacy of Oral Capecitabine versus Bolus 5-FU in Preoperative Radiotherapy of Locally Advanced Rectal Cancer. Journal of Korean Medical Science, 21, 52-57.
http://dx.doi.org/10.3346/jkms.2006.21.1.52